Clinical Trial Update: Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing eltrombopag for efficacy and safety in pediatric patients with chronic idiopathic thrombocytopenic purpura (ITP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura
• Purpura Thrombocytopaenic Idiopathic

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Purpura, Thrombocytopaenic, Idiopathic | Phase 2 | Status: COMPLETED | Results posted: 2014-10-31